Bellomo, Gaia, Rainer, Carolyn, Quaranta, Valeria, Astuti, Yuliana, Raymant, Meirion, Boyd, Elzbieta, Stafferton, Ruth, Campbell, Fiona, Ghaneh, Paula, Halloran, Christopher M 
ORCID: 0000-0002-5471-4178 et al (show 7 more authors)
(2022)
Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis.
Gut, 71 (11).
pp. 2284-2299.
Abstract
<jats:sec><jats:title>Objective</jats:title><jats:p>Pancreatic ductal adenocarcinoma (PDAC) is a highly metastatic disease and cytotoxic chemotherapy is the standard of care treatment for patients with advanced disease. Here, we investigate how the microenvironment in PDAC liver metastases reacts to chemotherapy and its role in metastatic disease progression post-treatment, an area which is poorly understood.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>The impact of chemotherapy on metastatic disease progression and immune cell infiltrates was characterised using flow and mass cytometry combined with transcriptional and histopathological analysis in experimental PDAC liver metastases mouse models. Findings were validated in patient derived liver metastases and in an autochthonous PDAC mouse model. Human and murine primary cell cocultures and ex vivo patient-derived liver explants were deployed to gain mechanistical insights on whether and how chemotherapy affects the metastatic tumour microenvironment.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>We show that in vivo, chemotherapy induces an initial infiltration of proinflammatory macrophages into the liver and activates cytotoxic T cells, leading only to a temporary restraining of metastatic disease progression. However, after stopping treatment, neutrophils are recruited to the metastatic liver via CXCL1 and 2 secretion by metastatic tumour cells. These neutrophils express growth arrest specific 6 (Gas6) which leads to AXL receptor activation on tumour cells enabling their regrowth. Disruption of neutrophil infiltration or inhibition of the Gas6/AXL signalling axis in combination with chemotherapy inhibits metastatic growth. Chemotherapy increases Gas6 expression in circulating neutrophils from patients with metastatic pancreatic cancer and recombinant Gas6 is sufficient to promote tumour cell proliferation ex vivo, in patient-derived metastatic liver explants.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Combining chemotherapy with Gas6/AXL or neutrophil targeted therapy could provide a therapeutic benefit for patients with metastatic pancreatic cancer.</jats:p></jats:sec>
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | liver metastases, pancreatic cancer, macrophages, immune response |
| Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 24 Jan 2022 10:52 |
| Last Modified: | 18 Jan 2023 21:14 |
| DOI: | 10.1136/gutjnl-2021-325272 |
| Open Access URL: | https://gut.bmj.com/content/early/2022/01/12/gutjn... |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3147537 |
Dimensions
Dimensions
